chr14-67762378-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015346.4(ZFYVE26):c.6194C>T(p.Ala2065Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2065S) has been classified as Uncertain significance.
Frequency
Consequence
NM_015346.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 15Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Myriad Women’s Health, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015346.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZFYVE26 | NM_015346.4 | MANE Select | c.6194C>T | p.Ala2065Val | missense | Exon 34 of 42 | NP_056161.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZFYVE26 | ENST00000347230.9 | TSL:1 MANE Select | c.6194C>T | p.Ala2065Val | missense | Exon 34 of 42 | ENSP00000251119.5 | ||
| ZFYVE26 | ENST00000555452.1 | TSL:1 | c.6194C>T | p.Ala2065Val | missense | Exon 34 of 35 | ENSP00000450603.1 | ||
| ZFYVE26 | ENST00000554523.5 | TSL:1 | n.6331C>T | non_coding_transcript_exon | Exon 34 of 41 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152176Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000917 AC: 23AN: 250794 AF XY: 0.0000737 show subpopulations
GnomAD4 exome AF: 0.0000691 AC: 101AN: 1461808Hom.: 0 Cov.: 32 AF XY: 0.0000646 AC XY: 47AN XY: 727204 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2065 of the ZFYVE26 protein (p.Ala2065Val). This variant is present in population databases (rs200312607, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ZFYVE26-related conditions. ClinVar contains an entry for this variant (Variation ID: 458289). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:1
ZFYVE26: PM2, BP4
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at